Limited coverage criteria – famotidine

Last updated on February 28, 2025

Generic name

famotidine

Strength & form

20 mg and 40 mg tablet

Special Authority criteria

Approval period

Treatment failure on prescription dose of, or intolerance to, ranitidine

Indefinite

Practitioner exemptions

  • Practitioners in the following specialty are not required to submit a Special Authority request form for coverage:
    • Pediatrics
    • Pediatric cardiology
    • Pediatric general surgery

Special notes

  • Prescription dose of ranitidine for adults is considered to be 150 mg twice daily or 300 mg once daily
  • Non-prescription use of famotidine is not eligible for PharmaCare coverage

Special Authority request form